Captrust Financial Advisors Gsk PLC Transaction History

Captrust Financial Advisors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$40.23 - $47.74 $1.18 Million - $1.4 Million	29,228 Added 3.22%	938,154 $41.4 Million
Q4 2021 Feb 14, 2022	SELL	$38.88 - $45.31 $157,813 - $183,913	-4,059 Reduced 0.44%	908,926 $40.5 Million
Q3 2021 Nov 16, 2021	BUY	$38.79 - $43.16 $5.43 Million - $6.04 Million	140,056 Added 18.12%	912,985 $35.4 Million
Q2 2021 Aug 16, 2021	BUY	$36.52 - $41.46 $6.04 Million - $6.85 Million	165,329 Added 27.21%	772,929 $31.1 Million
Q1 2021 May 17, 2021	BUY	$34.27 - $40.01 $287,422 - $335,563	8,387 Added 1.4%	607,600 $22.1 Million
Q4 2020 Feb 16, 2021	BUY	$34.07 - $39.94 $1.95 Million - $2.28 Million	57,208 Added 10.55%	599,213 $22.4 Million
Q3 2020 Nov 17, 2020	SELL	$38.11 - $42.99 $579,348 - $653,533	-15,202 Reduced 2.73%	542,005 $20.4 Million
Q2 2020 Aug 14, 2020	SELL	$37.87 - $43.58 $204,270 - $235,070	-5,394 Reduced 0.96%	557,207 $23 Million
Q1 2020 May 15, 2020	BUY	$32.47 - $48.83 $502,116 - $755,107	15,464 Added 2.83%	562,601 $21.2 Million
Q4 2019 Feb 14, 2020	BUY	$42.0 - $48.25 $23 Million - $26.4 Million	547,137 New	547,137 $25.9 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.